Source of previous anti-TB treatment for re-treatment TB cases registered under Revised National Tuberculosis Control Program in Pondicherry
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20173850Keywords:
Re-treatment TB, Time interval, Risk factors, Treatment after default, Relapse, FailureAbstract
Background: Re-treatment TB cases are still a big challenge to National TB control programme. The objectives of the study were among retreatment TB cases, to study the source of previous anti-TB treatment, to find the time delays in initiating re-treatment and to find the risk factors for initiating retreatment under Revised National Tuberculosis Control Program (RNTCP) in Pondicherry.
Methods: It was a cross sectional study. Source, date of completion or interruption of recent previous anti-TB treatment, missed doses, DM status; smoking and alcohol intake in the past TB treatment were collected using pretested structured questionnaire and available records. Data was entered in EpiData software version 3.1 and analysed using SPSS v20.
Results: Of 241 re-treatment TB patients, the proportion of relapse, TAD, failure and others were 52%, 24%, 12.4% and 11.6 respectively. About 90% [95% CI (85.6-93.2)] had received their recent previous anti-TB treatment from RNTCP sources. In multivariate analysis, Age >24 years, below secondary level of education and relapse cases have independently associated with RNTCP source of previous TB treatment. The median time interval of re-registration for relapse, TAD, failure and others were 334, 211, 140 and 53 days respectively. This difference between groups are statistically significant (p<0.0001). Almost one out of four retreatment TB patient was known diabetic. More than half of retreatment TB patients had consumed alcohol during their recent previous TB treatment.
Conclusions: The public-private partnership is better in Pondicherry as only 10% of re-treatment TB cases were previously treated from Non-RNTCP sources. There is a scope for reducing the time between declaration of failure and initiation of re-treatment TB regimen. Screening and appropriate counselling of all registered TB patients for smoking and alcohol intake may be necessary.
References
World Health Organization. Global Tuberculosis Report 2014.
Sachdeva KS, Satyanarayana S, Dewan PK, Nair SA, Reddy R, Kundu D, et al. Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010. PloS One. 2011;6(7):e22061.
TB India 2014 : Ministry of Health and Family Welfare. Available at: http://www.tbcindia.nic.in/ showfile.php?lid=3142. Accessed on 3 June 2017.
Satyanarayana S, Nair SA, Chadha SS, Shivashankar R, Sharma G, Yadav S, et al. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PloS One. 2011;6(9):e24160.
Vasudevan K, Jayakumar N, Gnanasekaran D. Smear Conversion, Treatment Outcomes and the Time of Default in Registered Tuberculosis Patients on RNTCP DOTS in Puducherry, Southern India. J Clin Diagn Res JCDR. 2014;8(10):5–8.
Charles N, Thomas B, Watson B, Raja Sakthivel M, Chandrasekeran V, Wares F. Care seeking behavior of chest symptomatics: a community based study done in South India after the implementation of the RNTCP. PloS One. 2010;5(9):e12379.
Sarpal SS, Goel NK, Kumar D, Janmeja AK. Gender disparities in retreatment patients of tuberculosis: A north Indian study. J Nat Sci Biol Med. 2015;6(1):63–6.
Sisodia RS, Wares DF, Sahu S, Chauhan LS, Zignol M. Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2006;10(12):1373–9.
Mukherjee A, Saha I, Sarkar A, Chowdhury R. Gender differences in notification rates, clinical forms and treatment outcome of tuberculosis patients under the RNTCP. Lung India Off Organ Indian Chest Soc. 2012;29(2):120–2.
Sarpal SS, Goel NK, Kumar D, Janmeja AK. Treatment Outcome Among the Retreatment Tuberculosis (TB) Patients under RNTCP in Chandigarh, India. J Clin Diagn Res JCDR. 2014;8(2):53–6.
Mukherjee A, Sarkar A, Saha I, Biswas B, Bhattacharyya PS. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India. Rural Remote Health. 2009;9(1):926.
Nakanwagi-Mukwaya A, Reid AJ, Fujiwara PI, Mugabe F, Kosgei RJ, Tayler-Smith K, et al. Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda. Public Health Action. 2013;3(2):149–55.
Ottmani SE, Zignol M, Bencheikh N, Laâsri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2006;10(12):1367–72.
Jha UM, Satyanarayana S, Dewan PK, Chadha S, Wares F, Sahu S, et al. Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006. PloS One. 2010;5(1):e8873.
Veerakumar AM, Sahu SK, Sarkar S, Kattimani S, Govindarajan S. Alcohol use disorders among pulmonary tuberculosis patients under RNTCP in urban Pondicherry, India. Indian J Tuberc. 2015;62(3):171–7.
Chandrasekaran V, Gopi PG, Santha T, Subramani R, Narayanan PR. Status of re-registered patients for tuberculosis treatment under DOTS programme. Indian J Tuberc. 2007;54(1):12–6.
Lee P-H, Lin H-C, Huang AS-E, Wei S-H, Lai M-S, Lin H-H. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PloS One. 2014;9(3):e92623.
Mehra RK, Dhingra VK, Nish A, Vashist RP. Study of relapse and failure cases of CAT I retreated with CAT II under RNTCP--an eleven year follow up. Indian J Tuberc. 2008;55(4):188–91.
Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2005;9(5):556–61.
Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG. Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PloS One. 2010;5(4):e10043.
Santha T, Garg R, Frieden T. R, Chandrasekaran V, Subramani R, Gopi P. G, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6(9):780–8.
Vijay S, Kumar P, Chauhan LS, Vollepore BH, Kizhakkethil UP, Rao SG. Risk factors associated with default among new smear positive TB patients treated under DOTS in India. PloS One. 2010;5(4):e10043.
Roy N, Basu M, Das S, Mandal A, Dutt D, Dasgupta S. Risk factors associated with default among tuberculosis patients in Darjeeling district of West Bengal, India. J Fam Med Prim Care. 2015;4(3):388–94.
Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PloS One. 2012;7(7):e41367.
Chachra V, Arora VK. Study on prevalance of diabetes mellitus in patients with T.B. under DOTS strategy. Indian J Tuberc. 2014;61(1):65–71.
Jali MV, Mahishale VK, Hiremath MB, Satyanarayana S, Kumar AMV, Nagaraja SB, et al. Diabetes mellitus and smoking among tuberculosis patients in a tertiary care centre in Karnataka, India. Public Health Action. 2013;3(1):51–3.
Veerakumar AM, Sahu SK, Sarkar S, Kattimani S, Govindarajan S. A study of alcohol and tobacco use among pulmonary tuberculosis patients in urban Pondicherry. JIPMER. 2015.
Suhadev M, Thomas BE, Raja Sakthivel M, Murugesan P, Chandrasekaran V, Charles N, et al. Alcohol use disorders (AUD) among tuberculosis patients: a study from Chennai, South India. PloS One. 2011;6(5):e19485.
Balasangameswara SVV, Jagannatha PS, Saroja VN, Kumar P. Defaults among tuberculosis patients treated under DOTS in Bangalore city: a search for solution. In: Presented at the 57th National Conference on Tuberculosis and Chest Diseases-Goa. 2002: 29.